United Kingdom

Nektar Therapeutics (NKTR.OQ)

NKTR.OQ on NASDAQ Stock Exchange Global Select Market

20 Mar 2019
Change (% chg)

$-1.80 (-5.23%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Robert Chess

61 2007 Independent Chairman of the Board

Howard Robin

65 2007 President, Chief Executive Officer, Director

Gilbert Labrucherie

46 2016 Chief Financial Officer, Senior Vice President

John Nicholson

66 2016 Chief Operating Officer, Senior Vice President

Jillian Thomsen

52 2010 Senior Vice President - Finance, Chief Accounting Officer